Skip to content
Skip to library content
Back to SteamcellSCE Educational LibraryStructured Educational Evidence Review · Dr. Mack Sullivan

Category 11

Safety, Complications, and Contraindications

10 topics planned. Each topic is published as a Professional and Patient edition only after explicit author approval.

  • 11.1Immediate reactions
    In preparation
    1. · Fever
    2. · Chills
    3. · Hypersensitivity
    4. · Anaphylaxis
    5. · Hypotension
    6. · Hypertension
    7. · Respiratory symptoms
  • 11.2Infection risks
    In preparation
    1. · Donor-derived infection
    2. · Processing contamination
    3. · Bacteremia
    4. · Sepsis
    5. · Mycoplasma
    6. · Viral transmission
    7. · Mold contamination
  • 11.3Immune risks
    In preparation
    1. · Alloimmunization
    2. · Antibody formation
    3. · Complement activation
    4. · Cytokine responses
    5. · Autoimmune activation
    6. · Immunosuppression
  • 11.4Thrombotic and embolic risks
    In preparation
    1. · Tissue factor
    2. · Coagulation activation
    3. · Microvascular obstruction
    4. · Venous thrombosis
    5. · Pulmonary embolic phenomena
    6. · Stroke risk
  • 11.5Abnormal tissue growth
    In preparation
    1. · Ectopic tissue
    2. · Fibrosis
    3. · Calcification
    4. · Uncontrolled proliferation
    5. · Tumor formation
    6. · Tumor-supporting signaling
  • 11.6Procedure-specific risks
    In preparation
    1. · Intra-articular injection
    2. · Intrathecal injection
    3. · Intracranial delivery
    4. · Intraocular injection
    5. · Intra-arterial delivery
    6. · Sedation and anesthesia
  • 11.7Organ-specific complications
    In preparation
    1. · Neurological injury
    2. · Blindness
    3. · Pulmonary injury
    4. · Cardiac complications
    5. · Renal injury
    6. · Hepatic injury
  • 11.8Contraindications and precautions
    In preparation
    1. · Active infection
    2. · Unstable malignancy
    3. · Coagulopathy
    4. · Severe cardiopulmonary disease
    5. · Pregnancy
    6. · Immunosuppression
    7. · Product-specific exclusions
  • 11.9Long-term surveillance
    In preparation
    1. · Delayed adverse events
    2. · Malignancy surveillance
    3. · Autoimmunity
    4. · Organ dysfunction
    5. · Reproductive effects
    6. · Registries
    7. · Loss to follow-up
  • 11.10Adverse-event reporting
    In preparation
    1. · Clinic reporting
    2. · Sponsor reporting
    3. · IRB reporting
    4. · FDA MedWatch
    5. · Product traceability
    6. · Patient documentation